Acculaser gains FDA green light for cold laser:
This article was originally published in Clinica
Executive Summary
Acculaser has gained clearance from the US FDA to market its cold laser technology as a non-surgical approach for treating pain associated with carpal tunnel syndrome. The condition, for which 200,000 surgical procedures are performed annually in the US, is characterised by chronic swelling of the tendons and nerves of the hand and wrist. The cold laser treatment, which can be given in the doctor's office by a trained therapist, avoids the risk of infection and other complications associated with surgery, and requires no recovery period, said the San Diego, California firm.